PCRX - Pacira BioSciences, Inc.
IEX Last Trade
19.575
-0.125 -0.639%
Share volume: 6,255
Last Updated: Fri 27 Dec 2024 05:29:25 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.45%
PREVIOUS CLOSE
CHG
CHG%
$19.70
-0.13
-0.63%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-28 | 2023-05-03 | 2023-08-02 | 2023-11-02 | 2024-02-29 | 2024-05-07 | 2024-07-30 | |
| Total revenue | 167.466 M | 171.955 M | 160.341 M | 169.467 M | 163.926 M | 181.244 M | 167.117 M | 178.023 M | |
| Cost of revenue | 50.678 M | 61.916 M | 49.020 M | 48.207 M | 39.750 M | 47.692 M | 47.416 M | 44.262 M | |
| Gross profit | 116.788 M | 110.039 M | 111.321 M | 121.260 M | 124.176 M | 133.552 M | 119.701 M | 133.761 M | |
| -5.78% | 1.17% | 8.93% | 2.40% | 7.55% | -10.37% | 11.75% | |||
| Operating expenses | 80.688 M | 81.475 M | 87.983 M | 83.674 M | 88.777 M | 85.264 M | 90.264 M | 88.464 M | |
| Selling general and admin | 61.283 M | 63.970 M | 70.843 M | 64.850 M | 67.947 M | 65.801 M | 72.026 M | 68.126 M | |
| Research and development | 19.405 M | 17.505 M | 17.140 M | 18.824 M | 20.830 M | 19.463 M | 18.238 M | 20.338 M | |
| Total expenses | 145.688 M | 157.713 M | 151.325 M | 146.203 M | 142.849 M | 147.278 M | 152.002 M | 147.048 M | |
| 8.25% | -4.05% | -3.38% | -2.29% | 3.10% | 3.21% | -3.26% | |||
| Operating income | 21.778 M | 14.242 M | 9.016 M | 23.264 M | 21.077 M | 33.966 M | 15.115 M | 30.975 M | |
| Ebit | 21.778 M | 14.242 M | 9.016 M | 23.264 M | 21.077 M | 33.966 M | 15.115 M | 30.975 M | |
| Pretax income | 2.069 M | -18.068 M | -26.474 M | 37.854 M | 16.601 M | 33.720 M | 13.640 M | 36.584 M | |
| -973.27% | 46.52% | -242.99% | -56.14% | 103.12% | -59.55% | 168.21% | |||
| Income tax | 2.762 M | -7.966 M | -6.938 M | 12.091 M | 5.743 M | 8.850 M | 4.661 M | 17.698 M | |
| Net income basic | -693.000 K | -10.102 M | -19.536 M | 25.763 M | 10.858 M | 24.870 M | 8.979 M | 18.886 M | |
| -1,357.72% | -93.39% | 231.87% | -57.85% | 129.05% | -63.90% | 110.34% | |||
| Net income | -693.000 K | -10.102 M | -19.536 M | 25.763 M | 10.858 M | 24.870 M | 8.979 M | 18.886 M | |
| -1,357.72% | -93.39% | 231.87% | -57.85% | 129.05% | -63.90% | 110.34% |